Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Achieve Life Sciences (ACHV) Accumulated Depreciation & Amortization (2016 - 2020)

Achieve Life Sciences (ACHV) has disclosed Accumulated Depreciation & Amortization for 9 consecutive years, with $632000.0 as the latest value for Q4 2020.

  • Quarterly Accumulated Depreciation & Amortization rose 5.33% to $632000.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $632000.0 through Dec 2020, up 5.33% year-over-year, with the annual reading at $632000.0 for FY2020, 5.33% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2020 was $632000.0 at Achieve Life Sciences, up from $600000.0 in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $1.4 million in Q4 2016, with the low at $600000.0 in Q4 2019.
  • Average Accumulated Depreciation & Amortization over 5 years is $897200.0, with a median of $720000.0 recorded in 2018.
  • The sharpest move saw Accumulated Depreciation & Amortization grew 13.11% in 2016, then crashed 33.64% in 2018.
  • Achieve Life Sciences' Accumulated Depreciation & Amortization stood at $1.4 million in 2016, then dropped by 25.12% to $1.1 million in 2017, then crashed by 33.64% to $720000.0 in 2018, then fell by 16.67% to $600000.0 in 2019, then increased by 5.33% to $632000.0 in 2020.
  • Per Business Quant, the three most recent readings for ACHV's Accumulated Depreciation & Amortization are $632000.0 (Q4 2020), $600000.0 (Q4 2019), and $720000.0 (Q4 2018).